Theravance Biopharma TBPH
TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Amortization of Deferred Charges (2019 - 2022)

Updated

Analysis

Theravance Biopharma (TBPH) Amortization of Deferred Charges (2019 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 341,000.00
Dec 31, 2021 1.03 Mn
Sep 30, 2021 1.01 Mn
Jun 30, 2021 1.01 Mn
Mar 31, 2021 743,000.00
Dec 31, 2020 1.13 Mn
Sep 30, 2020 793,000.00
Jun 30, 2020 963,000.00
Mar 31, 2020 457,000.00
Dec 31, 2019 195,000.00
Sep 30, 2019 1.01 Mn
Jun 30, 2019 1.03 Mn
Mar 31, 2019 986,000.00
API Access

Theravance Biopharma Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=TBPH&period=max&api_key=YOUR_API_KEY